Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,705 total articles
Hyundai is shifting strategy to emphasize hybrid models as BEV demand softens. That tactical pivot should protect near-term revenue and margins while maintaining optionality on battery electric vehicle growth. We initiate a long trade with a $8.50 entry, $11.00 target and $7.00 stop, horizon ~180 trading days.
We maintain a Strong Buy on Johnson & Johnson (JNJ). Valuation looks reasonable versus J&J's cash generation and defensive healthcare moat, and upcoming pipeline shots - notably SPY072 and potential IBD combination data in Q4 2026 - create asymmetric upside. Pair that with a 2.07% yield, $22.2B in free cash flow and a manageable balance sheet and t…
Rocket Lab's pending $8B acquisition of Iridium is the catalyst that could push the company from growth mode into meaningful profitability. Balance sheet strength and low debt make the deal plausible, but a GAO protest and integration execution create a binary outcome. We lay out an actionable trade with entry, stop and target, and why this is a mi…
Climb Global Solutions (CLMB) delivered a standout 2025 with 40% revenue growth and a clean balance sheet. The market is giving the company a premium multiple, but accelerating cloud and cybersecurity distribution, a recent EU tuck-in, and improving free cash flow make a controlled long trade attractive. This idea lays out an entry at $33.00, a sto…
Magna is showing sequential profit improvement, returning capital to shareholders and winning software-driven ADAS programs. The stock trades below prior highs on a reasonable EV/EBITDA and a mid-teens implied upside to the 52-week high. We recommend a position trade sized for medium risk with precise entry, stop and target.
United Internet (UTDI) trades at a persistent discount to its private-asset value. Operational stabilization at its core broadband business, an active capital-allocation pivot and a clearer path to monetizing minority stakes make it likely that the discount will shrink. This trade plan targets a gap-narrowing move over the next 180 trading days wit…
SL Green's recent leasing cadence and strategic asset moves — plus a yield near 5% and a below-par book multiple — give the stock asymmetric upside versus its current price. This trade idea lays out an actionable long with entry, target and stop, framed against the company's heavy leverage and cash-flow recovery risks.
PagSeguro (PAGS) is trading at a low-single-digit earnings multiple with improving technicals and a clear macro catalyst in Brazil's presidential runoff. This trade idea outlines a mid-term long with concrete entry, stops and targets while weighing the upside drivers and the key risks that could derail the setup.
Brookfield Renewable offers a high-distribution income stream backed by long-term contracted renewable assets. The business is durable and growth-capable, but the market is pricing a structural discount tied to rate, capex and payout concerns. This trade idea: take the yield at an attractive entry, protect capital with a strict stop, and treat any …
Diebold Nixdorf (DBD) trades at reasonable valuation metrics (EV/EBITDA ~7.8, P/E ~20) and generates meaningful free cash flow. The trade idea is a conditional long: buy on the expectation management will accelerate converting equipment and services backlog into cash and margin expansion. If that conversion stalls or macro-driven capex cuts hit ban…
Reddit has quietly re-accelerated user engagement and is expanding monetization beyond traditional display ads. For traders willing to accept platform and ad-cycle risk, a structured long trade captures upside from ad recovery, premium subscriptions and emerging commerce initiatives over the next 180 trading days.
We upgrade FLTR to a Buy and add to exposure at $25.52. The ETF yields roughly 4.3% (30-day SEC yield 4.24%) and sits near a psychologically low-volatility price range; technicals show short-term oversold conditions while short interest and heavy short volume create an asymmetric risk/reward for a tactical long position.
GSK at $47.10 offers a risk/reward where accelerating specialty medicines growth, recent bolt-on deals and a 3.8% yield matter more than near-term technical weakness. Enter a mid-term long (45 trading days) with tight risk management: entry $47.10, stop $44.00, target $57.00.
Silgan (SLGN) is a cash-rich, low-multiple packaging business trading near a year-low. At an entry of $32.40 the company's free cash flow yield clears 10%, creating a favorable asymmetric trade: limited downside to a conservative stop and meaningful upside if volumes and margins normalize and the market re-rates. This is a long-term trade (up to 18…
Eli Lilly remains the growth engine of big-cap healthcare thanks to Mounjaro and Zepbound, high margins, and expanding indications. The stock trades at a premium, but with consensus 2026 revenue approaching $89B and EPS growth still accelerating, a structured long into 10/29/2026 earnings with a defined stop offers an attractive risk/reward for swi…
Sezzle's recent pullback creates a low-risk entry to play accelerating subscriber growth, improving marketing ROI and expanding enterprise traction. Valuation is demanding on headline multiples, but cash flow generation and robust top-line momentum support a mid-term long trade with defined risk.
Lennar is trading around 0.85x book with a market cap near $18.0B, solid free cash flow, and a large new anchor investor in Berkshire Hathaway. The business is cyclical and earnings are under pressure, but the balance sheet and shareholder-friendly tailwinds create a structured, medium-risk long trade: entry $75.58, stop $67.00, target $95.00 over …
Alphabet trades at roughly 17x earnings with $53B of free cash flow and a fortress-like balance sheet. Short-term macro noise and AI capex headlines create entry points; we outline an actionable swing trade with defined entry, stop and target and explain the fundamental drivers and risks.
Akita Drilling's purchase of Fox Drilling meaningfully expands its operational footprint in North America. The combination should drive higher utilization and revenue optionality; given a $147M market cap and depressed share price versus the 52-week high, there's a tradeable long with defined risk. This idea lays out entry, stop, targets, catalysts…
Ironwood is a small-cap biotech trading at bargain multiples backed by solid LINZESS economics and meaningful free cash flow. The stock is fundamentally a call on the company executing and advancing a second Phase 3 apraglutide trial requested by regulators. If the company proves the program is on track, the re-rating can be substantial; failure or…
OR Royalties reported Q3 deliveries of 20,237 GEOs and $90.2M of revenue with a cash margin of 96.8%, left $76.7M of cash on the balance sheet, and still has significant available lending capacity. The stock trades at $34.47, well below a 52-week high of $48.06; we see tactical upside to $40.00 on continued GEO delivery growth, accretive small acqu…
dLocal's rapid TPV growth and exceptional net retention argue that recent margin compression is the byproduct of scaling into large enterprise flows and competitive pricing, not a permanent structural decline. At a $4.1B market cap and $14.53 stock price, the risk/reward favors a long, with a clear entry at $14.53, stop at $11.50 and a target of $2…
West Pharmaceutical (WST) is a well-capitalized, cash-generative supplier of containment and delivery systems for injectables. Recent dynamics - stronger HVP uptake, biopharma exposure, and regulatory-driven Annex 1 upgrades - support continued revenue and margin improvement. Valuation is rich (P/E ~46, EV/EBITDA ~28.8) so this is a buy with measur…
AvePoint is showing signs of durable cash generation and getting a direct demand lift from enterprises scrambling to govern AI. At a market cap just above $3.0B and free cash flow of $100.2M, the stock offers a mid-term trade with defined risk controls as sentiment and fundamentals drift higher.
FMAO looks cheap for a regional with $3.4B+ in assets, a $487M market cap, and improving profitability. Rising net interest margin (industry tailwinds plus local loan growth), a history of dividend increases and a conservative balance sheet create room for a re-rate to a mid-teens P/E. Entry at $35.40, target $42.00, stop $31.00 for a long-term (18…
